Hints and tips:
Related Special Reports
...So we’re sure this will end well. Further reading— Private debt is out of control (FTAV)— The private credit ‘golden moment’ (FTAV)...
...As a result, the financial effects of management quality are often measured by treating them as a residual....
...The International Capital Markets Association in September issued its first guidelines for blue bonds, which it is treating as a subset of the larger green bond market, rather than a new asset class in its...
...We also find that there is no breach of fiscal neutrality in treating the products as standard-rated. Further reading— Verbatim: What is a photocopier? (YouTube/The New York Times)...
...Looking at individual stock performance, the slowdown story holds as well....
...He also wrote to the US government to highlight the allegations, as well as wider concerns about the situation of low-paid workers in the country....
...It is likely to cost well above $10,000 a year per person....
...That is because of a tendency by oil majors to “massively over-engineer” renewable energy projects — say by treating a solar panel farm as if it was an oil rig. Is there any answer?...
...Investors appear to be treating the slowing sales as a cyclical rather than a secular change, and are looking though it. We can’t blame investors for being credulous....
...A version of this article was first published by Nikkei Asia on May 24, 2023. ©2023 Nikkei Inc. All rights reserved....
...A standing ovation in June greeted evidence of its success treating late-stage breast cancer....
...Ulta saw strong sales growth in haircare, skincare and fragrances as well....
...A similar case is described in a lawsuit in which UnitedHealthcare, America’s biggest health insurer, accuses Blackstone-owned TeamHealth of levying $100mn in bogus charges, including a $1,712 bill for treating...
...drugs regulator has rescinded its authorisation for the monoclonal antibody treatments made by Eli Lilly and Regeneron, which proved highly effective at fighting earlier strains of Covid-19 but do not work well...
...It is aimed at enhancing sleep quality and treating conditions such as long COVID and depression. There is no app involved at this stage and the rechargeable device is very simple to operate....
...However healthcare providers and insurers have been slow to embrace the drug, delaying purchasing decisions amid concerns over its high cost and doubts over its efficacy in treating the disease....
...The company is so well-known for its congenial office culture that it is colloquially referred to as T Rowe Nice....
...Vectura’s revenues from treating illnesses such as chronic obstructive pulmonary disease are crucial to its target of making $1bn in non-nicotine sales by 2025....
...subscribe to a malignant caricature of cigarette companies to see the issues — and to think Vectura’s board should have thought more about whether they were recommending a good buyer to shareholders, as well...
...The potential costs go well beyond just the medicine....
...Despite investment in drug trials, there are still few options for treating Covid-19, and there are concerns about how well Gilead’s remdesivir, the only antiviral that has been approved by the US regulator...
...The pricing of our medicines reflects these challenges as well as their life-changing benefits to patients and society.”...
...A version of this article was first published by Nikkei Asia on November 17. ©2021 Nikkei Inc. All rights reserved....
...Ant faces tortuous path back to market China’s banking regulator says it will begin treating fintech more like banks, further hampering Ant Group’s already-delayed IPO....
...He warned investors about treating the stock market like a casino and instead advised patient investment in companies with products that already have strong sales and a record of delivering profits....
International Edition